Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...

HRS/ACC statement guides expanded access for intracardiac ablation procedures in ambulatory surgical centers for appropriate patients.

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...

Thermedical has treated the first patient in a pivotal clinical trial of its saline-enhanced radiofrequency (SERF) ablation ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

Francis Medical designed its Vanquish system with needle guidance and hands-free stabilization for vapor ablation of the ...

Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...

A new scientific statement from the Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) lays out guiding principles around the performance of intracardiac ablation procedures in ...